Clinuvel PharmaceuticalsCUV 
$10.13-1.19%24h
-1.19%24h
Global rank11332
Market cap$500.75M
Change 7d-
YTD Performance-6.43%
SP500 benchmarkUnderperform
P/E17.15
P/S9.45
Revenue$52.99M
Earnings$20.71M
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Clinuvel Pharmaceuticals (CUV)
As of October 2024, Clinuvel Pharmaceuticals has a market cap of $500.75M. This makes Clinuvel Pharmaceuticals the world's 11332th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Clinuvel Pharmaceuticals from 2001 to 2024
-
Value:-
Market cap history of Clinuvel Pharmaceuticals from 2001 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $527.83M | -1.31% |
| 2023 | $534.85M | -26.17% |
| 2022 | $724.38M | -20.36% |
| 2021 | $909.57M | 21.91% |
| 2020 | $746.11M | -21.55% |
| 2019 | $951.02M | 57.18% |
| 2018 | $605.04M | 121.00% |
| 2017 | $273.77M | 9.93% |
| 2016 | $249.04M | 183.27% |
| 2015 | $87.92M | -37.38% |
| 2014 | $140.40M | 342.11% |
| 2013 | $31.76M | -48.09% |
| 2012 | $61.17M | 17.31% |
| 2011 | $52.15M | -24.64% |
| 2010 | $69.20M | -23.33% |
| 2009 | $90.26M | 12.50% |
| 2008 | $80.23M | -30.43% |
| 2007 | $115.33M | -52.41% |
| 2006 | $242.35M | 122.89% |
| 2005 | $108.73M | -63.04% |
| 2004 | $294.22M | 37.31% |
| 2003 | $214.27M | 415.38% |
| 2002 | $41.57M | -48.00% |
| 2001 | $79.95M | - |
CUV Market Cap Today is $500.75M -1.19% - 31 Oct 2024
View largest stocks by market cap 
